Annual report pursuant to Section 13 and 15(d)

Supplemental Balance Sheet and Cash Flow Information - Changes to Carrying Amount of Net Intangible Assets (Details)

v3.22.2.2
Supplemental Balance Sheet and Cash Flow Information - Changes to Carrying Amount of Net Intangible Assets (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Beginning balance   $ 615,968 $ 516,545
Acquisitions     153,311
Other additions   293 5,912
Amortization expense   (74,147) (64,940)
Currency translation   (2,029) 5,140
Eminence impairment (1)   (8,563)  
Ending balance   531,522 $ 615,968
Changzhou Eminence Biotechnology [Member]      
Eminence impairment (1) $ (8,600) $ (8,600)